Showing results (631-640 of 640) with videos related to

Sort By:
Pageof 64
You have reached the last page of results.This site can display upto 640 results.
Fortschritte Der Medizin. Originalien|January 22, 2004
[Hypertension, diabetes mellitus and comorbidity in primary care]H U Wittchen, P Krause, M Höfler, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 15, 2014
Aldosterone to active Renin ratio as screening test for primary aldosteronism: reproducibility and influence of orthostasis and salt loadingS Pilz, K Kienreich, M Gaksch, et al.
Atherosclerosis|May 23, 2001
Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiencyA G Bostom, F Kronenberg, R Y Gohh, et al.
Atherosclerosis|November 2, 2001
Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rateA G Bostom, F Kronenberg, P F Jacques, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 20, 1998
Comparing outcomes in renal replacement therapy: how should we correct for case mix?I H Khan, M K Campbell, D Cantarovich, et al.
Diabetologia|March 4, 1999
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaBM A Hofmann, S Schiekofer, B Isermann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2000
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 studyC R Ramsay, M K Campbell, D Cantarovich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 1996
Survival on renal replacement therapy in Europe: is there a 'centre effect'?I H Khan, M K Campbell, D Cantarovich, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 31, 2004
A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetesG Rudofsky, B Isermann, T Schilling, et al.
The Journal of Pathology|December 9, 1997
The Heidelberg classification of renal cell tumoursG Kovacs, M Akhtar, B J Beckwith, et al.
Pageof 64